# Multi-marker Approach for Risk Assessment in PAH

> **NCT03954405** · — · UNKNOWN · sponsor: **Wuhan Asia Heart Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03954405
- **Lead sponsor:** Wuhan Asia Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954405, "Multi-marker Approach for Risk Assessment in PAH". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03954405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*